These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3908902

  • 1. [Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice].
    Moriya N.
    Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1470-9. PubMed ID: 3908902
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
    Fuks BB, Rakhmilevich AL, Pimenov AA, Dubrovskaia AG.
    Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
    Inagawa H, Nishizawa T, Noguchi K, Minamimura M, Takagi K, Goto S, Soma G, Mizuno D.
    Anticancer Res; 1997 Oct; 17(3C):2153-8. PubMed ID: 9216680
    [Abstract] [Full Text] [Related]

  • 9. Exhaustive exercise reduces tumor necrosis factor-alpha production in response to lipopolysaccharide in mice.
    Tanaka Y, Kawanishi N, Shiva D, Tsutsumi N, Uchida M, Kitamura H, Kato Y, Yano H.
    Neuroimmunomodulation; 2010 Oct; 17(4):279-86. PubMed ID: 20203534
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis.
    Zuckerman SH, Shellhaas J, Butler LD.
    Eur J Immunol; 1989 Feb; 19(2):301-5. PubMed ID: 2784766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide and tumor necrosis factor-alpha induce lipopolysaccharide receptor expression on bone marrow cells by different mechanisms.
    Chaby R, Pedron T, Stütz PL, Girard R.
    J Immunol; 1993 Nov 01; 151(9):4476-85. PubMed ID: 7691950
    [Abstract] [Full Text] [Related]

  • 16. Combination immunotherapy of cancer in a mouse model: synergism between tumor necrosis factor and other defense systems.
    Chun M, Hoffmann MK.
    Cancer Res; 1987 Jan 01; 47(1):115-8. PubMed ID: 3791198
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y, Yamamoto Y, Kamada H, Tsunoda S, Tsutsumi Y, Hirano T, Mayumi T.
    Cancer Res; 1998 Jan 15; 58(2):290-5. PubMed ID: 9443407
    [Abstract] [Full Text] [Related]

  • 18. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.
    Creasey AA, Reynolds MT, Laird W.
    Cancer Res; 1986 Nov 15; 46(11):5687-90. PubMed ID: 3756916
    [Abstract] [Full Text] [Related]

  • 19. [Antitumor activity of recombinant human tumor necrosis factor (TNF)].
    Somura K, Nakano K, Abe M, Nakata K, Yoshida H.
    Gan To Kagaku Ryoho; 1985 Jan 15; 12(1):160-2. PubMed ID: 3966807
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.